Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Doripenem – A New Broad-Spectrum Carabapenem Antibiotic

Drug (Brand/Generic)

Doripenem

Company/Licensee

Shionogi/J&J

Therapy Class

ß-lactam (carbapenem)

Product Description

Antibiotic

Current Indication

Treatment of intra-abdominal and urinary tract infections

Market Sector

Anti-infectives

Development Status

Approved in the US, Japan and Europe
Expand
Close
Close
Close

Go Top